Cognitive Training to Improve Cognitive Function Following Chemotherapy (KT)
Recruitment status was Not yet recruiting
The purpose of this study is to improve cognitive dysfunction following chemotherapy, the investigators investigated to see whether a cognitive training for memory and concentration skills can improve cognitive performance in patients following cancer treatment.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Training of Cognitive Function of Patients After Chemotherapy|
- several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3) [ Time Frame: one weeks following the end of the cognitive training ] [ Designated as safety issue: No ]
- quality of life and subjective perception of cognitive problems [ Time Frame: 7 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||December 2009|
|Estimated Study Completion Date:||October 2011|
|Estimated Primary Completion Date:||October 2011 (Final data collection date for primary outcome measure)|
Patients in this group start the cognitive training over 6 weeks directly after randomization.
Behavioral: cognitive training
cognitive training over 6 weeks, consist of 6 meetings (a 45minutes), three sessions focus on concentration tasks and three sessions on memory problems.
Other Name: training group
Placebo Comparator: control
In this control group begin the training in a cross-over design 7 weeks after randomization.
Other: control group
Other Name: controll group
Patients following chemotherapy invited for a cognitive training. Before and after cognitive function will evaluate.
|Contact: Susanne Effenberger, MScfirstname.lastname@example.org|
|Contact: Fernando Dimeo, MDemail@example.com|
|Charite Universitätsmedizin Berlin||Not yet recruiting|
|Berlin, Germany, 12200|
|Contact: Susanne Effenberger, MSc +49-30-8445-2410 firstname.lastname@example.org|
|Principal Investigator: susanne Effenberger, MSc|
|Principal Investigator:||Michael Niedeggen, PhD||Freie Universität Berlin|